Miscellaneous News

RSS
Researchers explore difference in reactions to SARS-CoV-2 infection between children and adults

Researchers explore difference in reactions to SARS-CoV-2 infection between children and adults

Researchers develop innovative profiling methods for SARS-CoV-2 infection

Researchers develop innovative profiling methods for SARS-CoV-2 infection

White-tailed deer susceptible to SARS-CoV-2, finds study

White-tailed deer susceptible to SARS-CoV-2, finds study

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

Why does convalescent plasma therapy for severe COVID-19 show mixed success?

Why does convalescent plasma therapy for severe COVID-19 show mixed success?

Study suggests COVID-19 vaccine acceptance on the rise in UK

Study suggests COVID-19 vaccine acceptance on the rise in UK

SARS-CoV-2 can infect blood monocytes and trigger inflammation, finds study

SARS-CoV-2 can infect blood monocytes and trigger inflammation, finds study

Could an “ACE2 Triple Decoy” be an alternative approach to neutralizing SARS-CoV-2?

Could an “ACE2 Triple Decoy” be an alternative approach to neutralizing SARS-CoV-2?

Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

Researchers characterize antibody responses to COVID-19 mRNA-based vaccine

A genetic variant of TMPRSS2 may confer protection against severe COVID-19

A genetic variant of TMPRSS2 may confer protection against severe COVID-19

Ultraviolet light therapy reduces viral load in critically ill COVID-19 patients

Ultraviolet light therapy reduces viral load in critically ill COVID-19 patients

Small negative lifestyle changes during COVID-19 lockdown could accumulate, say researchers

Small negative lifestyle changes during COVID-19 lockdown could accumulate, say researchers

A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo

A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo

Identification of neutralizing IFNL3 autoantibodies in severe COVID-19 cases

Identification of neutralizing IFNL3 autoantibodies in severe COVID-19 cases

Novel host-viral-microbiome interactions during COVID-19 may determine outcome

Novel host-viral-microbiome interactions during COVID-19 may determine outcome

Researchers detect vaccine-induced SARS-CoV-2 antibodies in breast milk

Researchers detect vaccine-induced SARS-CoV-2 antibodies in breast milk

Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination

Successful SARS-CoV-2 vaccination hinges on non-pharmaceutical interventions and vaccine deployment strategies

Successful SARS-CoV-2 vaccination hinges on non-pharmaceutical interventions and vaccine deployment strategies

Researchers evaluate surrogate large-scale SARS-CoV-2 serosurveillance test

Researchers evaluate surrogate large-scale SARS-CoV-2 serosurveillance test

Researchers to conduct large meta-analysis of fetomaternal complications in COVID-19

Researchers to conduct large meta-analysis of fetomaternal complications in COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.